Source: Annual Congress 2006 - COPD therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Celli, A. Emmett, G. Crater, C. Kalberg (Boston, Research Triangle Park, United States Of America). Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 4395

Member's Comments

No comment yet.

Related content which might interest you: Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 86-94 Year: 2004 Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Source: Eur Respir J 2006; 28: 939-944 Year: 2006 Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Mechanisms limiting exercise in COPD: new insights Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease Year: 2005 The effect of non-invasive ventilation (NIV) during exercise on inspiratory capacity (IC) and endurance time (Tlim) in patients with severe COPD Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019 Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Source: Eur Respir J 2012; 40: 322-329 Year: 2012 Inspiratory capacity (IC) and dyspnea during recovery from symptom-limited exercise in COPD patients treated with tiotropium Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004 New strategies to improve exercise capacity in COPD Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD Year: 2006 Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Source: Eur Respir J 2004; 23: 832-840 Year: 2004 Fat-free mass depletion and functional exercise capacity in COPD patients Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD Source: Eur Respir J 2004; 24: 385-390 Year: 2004 Comparing interval and continuous endurance training in COPD Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Tiotropium improves walking endurance in COPD Source: Eur Respir J 2012; 39: 265-271 Year: 2012 Changes of active expiration respiratory muscle (RM) in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Respiratory and skeletal muscle assessment in health and disease Year: 2011 Differences between walking and stair climbing in severe COPD patients receiving and not receiving long-term NIV Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation Year: 2007 Respiratory muscle unloading improves peripheral muscle oxygenation during high-intensity, constant work rate exercise in patients with moderate to severe COPD Source: Annual Congress 2007 - Exercise: respiratory muscle fatigue and dynamic hyperinflation Year: 2007 Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients Source: Eur Respir J 2001; 18: 77-84 Year: 2001